☆ 4.8 Article

Integrative analysis of single-cell transcriptomics reveals age-associated immune landscape of glioblastoma

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors

Adam Lauko et al.

Summary: Brain tumors, particularly glioblastoma (GBM), remain challenging to treat due to unique challenges like the blood-brain barrier and immunosuppressive environment, as well as tumor heterogeneity, plasticity, and cancer stem cells within GBM. Despite unchanged standard of care since 2005, advances in understanding tumor heterogeneity and plasticity are unlocking new therapeutic opportunities and potential breakthroughs.

SEMINARS IN CANCER BIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

Nourhan Abdelfattah et al.

Summary: This study identifies molecular phenotypes of immune-suppressive and -promoting myeloid cells in GBM through single cell RNA sequencing and discovers S100A4 as a regulator of immune suppressive T and myeloid cells in GBM. The study reveals extensive spatial and molecular heterogeneity in immune infiltrates and identifies nine distinct myeloid cell subtypes, with five being prognostic indicators of glioma patient survival.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Immunology

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma

Zeyu Wang et al.

Summary: In this study, the role of the aldehyde dehydrogenase family in gliomas was explored through bulk RNA-seq analysis and single-cell RNA-Seq analysis. The results showed that high-scoring samples based on the aldehyde dehydrogenases family were associated with worse survival outcomes. Pathway enrichment scores were calculated to validate the biofunction prediction results, indicating that the aldehyde dehydrogenases family influenced glioma progression by modulating tumor cell proliferation, migration, and immune landscape. ALDH3B1 and ALDH16A1, two main contributors to the scoring system, were found to affect glioblastoma cell proliferation and migration through cell-cycle arrest and the epithelial-mesenchymal transition.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Single-cell immunology: Past, present, and future

Florent Ginhoux et al.

Summary: The immune system is a complex, dynamic, and plastic ecosystem composed of multiple cell types. The advent of single-cell genomic approaches has revolutionized our knowledge of the cellular and molecular makeup of the immune system. Integration of multiomics at the single-cell level will pave the way for future advances in immunology research and clinical translation.

IMMUNITY (2022)

Add to Collection

Article Immunology

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression

Alan T. Yeo et al.

Summary: Using single-cell transcriptomics and flow cytometry, this study investigated the changes in immune cell composition during the progression of glioblastoma (GBM). The results revealed a transition from pro-inflammatory microglia to infiltrating macrophages and suppressor cells as the tumor advanced.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma

Paris M. M. Kollis et al.

Summary: This study characterized the chemokine receptor and integrin expression profiles of endogenous glioblastoma-infiltrating T cells and identified potential homing receptor-ligand pairs that could enhance the tumour-homing properties of future T-cell immunotherapies for glioblastoma.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Single-Cell Transcriptomics Revealed Subtype-Specific Tumor Immune Microenvironments in Human Glioblastomas

Yong Xiao et al.

Summary: This study characterized the cellular diversity and interactions in the tumor microenvironment of human glioblastoma using single-cell transcriptome sequencing. The results revealed the functional differences and roles of different tumor subtypes in the immune microenvironment, providing insights for patient stratification and personalized treatment.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma

Vidhya M. Ravi et al.

Summary: This study utilizes spatially resolved transcriptomics, metabolomics, and proteomics to characterize glioblastomas and uncover their spatial organization and adaptive mechanisms to inflammatory and metabolic stimuli. The integration of metabolic imaging and imaging mass cytometry reveals the interdependence between tumor and host in a locoregional manner, leading to spatially exclusive adaptive transcriptional programs. The findings confirm the importance of environmental stress in shaping glioblastoma subclones and their transcriptional programs.

CANCER CELL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Glioma progression is shaped by genetic evolution and microenvironment interactions

Frederick S. Varn et al.

Summary: This study analyzed RNA and DNA sequencing data from tumor pairs of patients with IDH-wild-type and IDH-mutant glioma, and identified the factors driving therapy resistance and recurrence. The results showed that IDH status, histological features, somatic alterations, and microenvironment interactions play important roles in glioma recurrence. Furthermore, specific cellular and genetic changes were associated with tumor growth, invasion, and neuronal interactions, providing potential targets for altering disease progression.

CELL (2022)

Add to Collection

Article Medicine, General & Internal

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

Jaime Gallego Perez-Larraya et al.

Summary: This study investigated the use of oncolytic virus DNX-2401 in pediatric patients with diffuse intrinsic pontine glioma (DIPG). The results showed that treatment with DNX-2401 led to changes in T-cell activity and reduction or stabilization of tumor size in some patients, but also caused adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Immunology

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy

Peng Feng et al.

Summary: Glioblastoma multiforme (GBM) is a frequently occurring adult primary brain cancer with high aggressiveness. Immunotherapy has potential in treating GBM, but the complex tumor microenvironment poses challenges. In this study, different subtypes of immune cell infiltration were identified through clustering analysis, and gene cluster A with a hot immune cell infiltration phenotype was found to have a better prognosis and improved immunotherapy response.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma

Yesen Zhang et al.

Summary: This study identified potential prognostic biomarkers for GBM (Glioblastoma) using gene expression profiles and co-expression analysis, as well as discovering prognosis-related genes and potential therapeutic targets.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Oncology

Single-Cell Transcriptome Profiling Signatures and Alterations of Microglia Associated With Glioblastoma Associate Microglia Contribution to Tumor Formation

Hailong Xia et al.

Summary: Glioblastoma (GBM), the most common tumor of the central nervous system in adults, has limited effective treatment methods. This study used single-cell RNA-seq data to reveal the heterogeneity of microglia cells in GBM tumor lesions and explored their roles in the development of GBM.

PATHOLOGY & ONCOLOGY RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion

Ester Gangoso et al.

Summary: In this study, it was found that GBM stem cells acquire the ability to evade immune clearance through epigenetic immunoediting, leading to the formation of an immunosuppressive tumor microenvironment. This process is not driven by genetic selection but by altering the transcriptional and epigenetic profile of GSCs after immune attack.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma

Zihao Yan et al.

Summary: This study established a T-cell activation-related risk score based on mRNA expression profiles to evaluate the prognosis and immunotherapy response of GBM patients. The high-risk group had poorer prognosis, stronger immune response, and a more complex tumor immune microenvironment. The immunotherapy score obtained by combining the risk and priming scores was found to be a good evaluation index for ICB response in GBM patients, providing potential treatment opportunities.

PEERJ (2021)

Add to Collection

Article Immunology

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha

Karen De Vlaminck et al.

Summary: Single-cell RNA sequencing of human GBM samples revealed significant expression of SIRP alpha in myeloid cells, suggesting its potential as a target for nanobodies in mouse models. Analysis of different nanobody structures showed that small monovalent nanobodies have better tumor penetration and biodistribution characteristics.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Neurosciences

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Ana Rita Pombo Antunes et al.

Summary: By utilizing single-cell RNA sequencing and CITE-seq, this study reveals the complexity of the immune landscape in glioblastomas, including conserved populations of dendritic cells and macrophages. The results indicate that microglia-derived tumor-associated macrophages dominate in newly diagnosed tumors, but are replaced by monocyte-derived TAMs in recurrences.

NATURE NEUROSCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.

CELL (2021)

Add to Collection

Article Cell Biology

Exploring the longitudinal glioma microenvironment landscape uncovers reprogrammed pro-tumorigenic neutrophils in the bone marrow

Prerna Magod et al.

Summary: Recent multi-omics studies have shown different compositions of the immune tumor microenvironment (TME) in glioblastoma (GBM). This study focused on the cellular evolution of the TME in murine GBM models initiated from different oncogenic drivers. It revealed that neutrophils infiltrate early during tumor progression, primarily in the mesenchymal GBM model. Depletion of neutrophils at the onset of disease was found to accelerate tumor growth and decrease mouse survival time, indicating a potential point of intervention in GBM treatment.

CELL REPORTS (2021)

Add to Collection

Article Immunology

Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma

Sheng Tu et al.

Summary: Tumor-associated microglia/macrophages (TAM/Ms) and CD8+ T cells are crucial immune cells in glioblastoma, and their interaction has potential targets to overcome malignancy. Understanding the molecular factors and crosstalk between these two cell types can impact the immune status and treatment outcomes in glioblastoma. Novel therapeutic targets, including reprogramming TAM/Ms and TAM/Ms-CD8+ T cell cofactors, may offer translational usage in addressing the challenges of this crosstalk in glioblastoma treatment.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Oncology

Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity

Laura M. Richards et al.

Summary: The study revealed that glioblastomas contain diverse cell populations, with GSCs showing high transcriptional heterogeneity associated with normal neural development and inflammatory wound response. Genome-wide CRISPR-Cas9 dropout screens validated this observation. Additionally, the majority of malignant cells were found to organize along an orthogonal astrocyte maturation gradient while retaining founder GSC transcriptional programs.

NATURE CANCER (2021)

Add to Collection

Review Pharmacology & Pharmacy

Advanced Immunotherapy Approaches for Glioblastoma

Yifan Ma et al.

Summary: Glioblastoma multiforme (GBM) is the most aggressive primary central nervous system tumor, and immunotherapy has emerged as a promising approach for treating GBM, especially in combination with other classical cancer therapies. Additional systematic and in-depth investigations are required to further improve the efficacy of GBM immunotherapy for future clinical applications.

ADVANCED THERAPEUTICS (2021)

Add to Collection

Article Multidisciplinary Sciences

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

Joseph A. Flores-Toro et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes

Ekaterina Friebel et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells

Florian Klemm et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies

Kai Yu et al.

NATIONAL SCIENCE REVIEW (2020)

Add to Collection

Article Oncology

Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

Erik Ladomersky et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders

Devika Agarwal et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Oncology

Brain immunology and immunotherapy in brain tumours

John H. Sampson et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

CELL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Single-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity

Joshua D. Welch et al.

CELL (2019)

Add to Collection

Review Neurosciences

Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology

David H. Gutmann et al.

NEURON (2019)

Add to Collection

Review Oncology

Glioblastoma Therapy in the Age of Molecular Medicine

Luiz Henrique Medeiros Geraldo et al.

TRENDS IN CANCER (2019)

Add to Collection

Review Immunology

Immune Microenvironment in Glioblastoma Subtypes

Zhihong Chen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Medicine, General & Internal

Acute myeloid leukaemia

Nicholas J. Short et al.

LANCET (2018)

Add to Collection

Article Multidisciplinary Sciences

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Andrew S. Venteicher et al.

SCIENCE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

CD4+Foxp3- type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages

Zhao Li et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Add to Collection

Article Cell Biology

Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth

Wenchao Zhou et al.

NATURE CELL BIOLOGY (2015)

Add to Collection

Review Geriatrics & Gerontology

Treatment options and outcomes for glioblastoma in the elderly patient

Nils D. Arvold et al.

CLINICAL INTERVENTIONS IN AGING (2014)

Add to Collection

Article Oncology

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009

Therese A. Dolecek et al.

NEURO-ONCOLOGY (2012)

Add to Collection

Review Neurosciences

Current Trends in Targeted Therapies for Glioblastoma Multiforme

Fumiharu Ohka et al.

NEUROLOGY RESEARCH INTERNATIONAL (2012)

Add to Collection

Article Oncology

Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy

Xinmei Zhu et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Add to Collection

Article Oncology

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients

G. Minniti et al.

JOURNAL OF NEURO-ONCOLOGY (2008)

Add to Collection

Article Oncology

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

Justin T. Jordan et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Add to Collection

Article Oncology

Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

KR Lamborn et al.

NEURO-ONCOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.